class action lawsuit

Class action lawsuit filed against Bath & Body Works for allegedly making false growth claims. Investors who suffered losses between June 2024 and November 2025 may seek damages.

NuScale Power faces securities lawsuit alleging material misrepresentations about ENTRA1 partnership synergies. Class action targets investors who purchased shares May-November 2025.

Class action securities fraud lawsuits filed against Klarna, Agilon Health, and Fermi. Investor lead plaintiff deadlines range from February 20 to March 6, 2026.

BellRing Brands faces securities lawsuit alleging false sales disclosures. Stock fell 51.6% after company allegedly misattributed inventory hoarding to market demand.

SDM shareholders have until March 16, 2026 to join a securities fraud class action after the stock collapsed 88% due to alleged market manipulation and insider trading violations.

Paysafe faces securities fraud lawsuit after missing revenue targets by $5.8M and reporting $87.7M loss. Stock fell 27.6%. Shareholders have April deadline to file.

BellRing Brands faces securities fraud lawsuit alleging it misrepresented sales growth, claiming inventory stockpiling rather than organic demand drove performance, inflating stock valuations.

Class action filed against Ramaco Resources (METC) alleging misrepresentations about Brook Mine operations. Stock fell 9.6%; investors from July-October 2025 eligible to join lawsuit.

Class action lawsuit filed against Varonis Systems alleging executives made false statements about SaaS conversion capabilities, concealing migration challenges while maintaining revenue guidance.

BlackRock TCP Capital faces class action lawsuit alleging false valuations and misleading net asset value disclosures. Shareholders who bought shares between November 2024 and January 2026 may participate.

Beyond Meat faces class action lawsuit alleging leadership concealed material asset impairment charges, misleading investors during nine-month period ending November 2025.

Paysafe Limited faces class action lawsuit alleging undisclosed risks including high-risk client concentration and understated credit reserves, misleading investors about financial stability.

CIBC and RBC face class action lawsuit for allegedly using spoofed orders to manipulate Quantum Biopharma stock price downward, harming investors from 2021-2025.

Class action lawsuit filed against Picard Medical for alleged fraud involving false social media statements and insider stock sales during inflated prices.

Class action lawsuit filed against Inovio Pharmaceuticals for allegedly making false statements about device manufacturing capabilities and regulatory timelines between October 2023 and December 2025.

Masonite faces class action lawsuit alleging executives concealed acquisition offers while repurchasing stock at depressed prices. Investors who bought shares June 2023-February 2024 are eligible.

Class action lawsuit filed against CoreWeave for allegedly making false statements about operational capabilities and customer demand fulfillment. Investors who purchased stock during specified period may seek lead plaintiff status.

uniQure faces class action lawsuit alleging misleading FDA approval statements and understated BLA timeline risks. Investors who purchased securities between September-October 2025 may be eligible to participate.

REGENXBIO faces securities class action alleging false statements about RGX-111 gene therapy program and clinical trial outcomes. Investors from February 2022-January 2026 may recover damages.

Portnoy Law Firm filed securities class action against Ultragenyx Pharmaceutical, alleging the company made false statements about investigational drug setrusumab and concealed material clinical trial risks.